Onconic Therapeutics Inc. (KOSDAQ:476060)
18,800
-1,200 (-6.00%)
At close: Mar 9, 2026
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 843.89 billion as of March 9, 2026. Its market cap has increased by 418.66% in one year.
Market Cap
843.89B
Enterprise Value
790.48B
Revenue
46.65B
Ranking
n/a
PE Ratio
12.42
Stock Price
18,800.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 843.89B, an increase of 351.50%. That is a compound annual growth rate of 247.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 897.76B | 3.22% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDIPOST | 906.79B |
| Pharmicell | 870.06B |
| Medy-Tox | 862.73B |
| Proteina | 854.37B |
| GI Innovation | 974.15B |
| Green Cross Holdings | 637.89B |
| SillaJen | 477.93B |
| Genomictree | 464.95B |